1. Home
  2. Directory
  3. North Carolina
  4. Lumberton
  5. Family Medicine
  6. NPI Profile
  7. Prescriptions 1912236613

MUHAMMAD SARFRAZ ZAFAR M.D.
Prescription History 1912236613
Family Medicine in Lumberton, NC

NPI Status: Active since December 09, 2009

Contact Information

300 W 27TH ST
LUMBERTON, NC
ZIP 28358
Phone: (910) 671-5000
Fax: (910) 738-3764

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MUHAMMAD SARFRAZ ZAFAR M.D., an active Family Medicine specialist practicing in Lumberton, NC. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 61 documented patient claims. Among these therapy options, the most frequently utilized medication is Lisinopril, which accounts for 23 claims alone.

Medication Index

E
L
M
P
No matching medications currently found on file.

Eliquis

Generic Formulation: ApixabanSpecialty: Family Practice
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 445
NC State Average Benchmarks
Peer Average Claims84.0
Peer Average 30-Day Fills126.3
Peer Average Days Supply3,570
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 81.0% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,858.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$553.68

State Avg Cost Per Claim

$781.62

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Family Practice
Provider Metrics Summary
Total Claims 23
30-Day Fills 24.0
Days Supply 600
NC State Average Benchmarks
Peer Average Claims111.0
Peer Average 30-Day Fills266.7
Peer Average Days Supply7,931
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.3% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $258.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.22

State Avg Cost Per Claim

$7.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Morphine Sulfate

Generic Formulation: Morphine SulfateSpecialty: Family Practice
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 150
NC State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills29.9
Peer Average Days Supply735
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 62.1% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $136.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.39

State Avg Cost Per Claim

$32.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Pantoprazole Sodium

Generic Formulation: Pantoprazole SodiumSpecialty: Family Practice
Provider Metrics Summary
Total Claims 11
30-Day Fills 12.0
Days Supply 360
NC State Average Benchmarks
Peer Average Claims80.0
Peer Average 30-Day Fills168.5
Peer Average Days Supply4,985
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 86.3% less volume than the regional standard for practitioners inside NC. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $83.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.63

State Avg Cost Per Claim

$16.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.

Therapeutic Applications

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MUHAMMAD SARFRAZ ZAFAR M.D. provides transparency into local medical care patterns within Lumberton, NC.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Family Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.